7012 Werts et al.
Macromolecules, Vol. 36, No. 19, 2003
(m, 10H), 8.74 (s, 1H), 9.44-9.50 (m, 6H), 9.60 (d, 2H).
MALDI-TOF: m/z 2603 (M - 2PF6)+, 2458 (M - 3PF6)+, 2313
(M - 4PF6)+. Anal. Calcd for C146H154F24N4O20P4Si: C, 60.62;
H, 5.37; N, 1.94. Found: C, 60.25; H, 5.38; N, 2.02. Thus, 95%
of the unthreaded dumbbell could be recovered by column
chromatography of the ether phase [SiO2, CH2Cl2:acetone (9:
1)].
mmol) in MeCN (0.7 mL). After 30 min at room temperature,
CH2Cl2 was added, and the resulting solution was extracted
twice with H2O/NH4PF6 and twice with water. The rotaxane
was precipitated from the organic phase with Et2O, yielding
the product as a red solid (42 mg, 75%). 1H NMR (acetone-d6):
δ 2.34 (quintet, 2H), 2.76 (t, 2H), 3.75-4.15 (m, 48H), 4.69-
4.75 (m, 4H), 5.35 (d, 1H), 5.47 (d, 1H), 6.10 (m, 1H), 6.20 (s,
4H), 6.31 (s, 2H), 6.52 (s, 2H), 6.85-6.98 (m, 6H), 7.10 (d, 2H),
7.16-7.21 (m, 6H), 7.28-7.45 (m, 21H), 8.18 (s, 4H), 8.32-
8.42 (m, 10H), 8.74 (s, 1H), 9.44-9.50 (m, 6H), 9.60 (d, 2H).
MALDI-TOF (dihydroxybenzoic acid matrix): m/z 2365 (M
- 2PF6)+, 2220 (M - 3PF6)+, 2075 (M - 4PF6)+.
{[1-{p -[2-(2-(2-(2-(D i p h e n y lm e t h o x y )e t h o x y )e t h -
oxy)eth oxy)eth oxy] ph en oxy}-13-{p-[2-(2-(2-(2-[4-((diph en -
yl-t er t -b u t yl)siloxy)p h e n yl]p h e n ylm e t h oxy)e t h oxy)-
eth oxy)eth oxy)eth oxy]p h en oxy}-3,6,9-tr ioxa u n d eca n e]-
[cyclo(2,5-(p a r a q u a t -p -p h en ylen ep a r a q u a t )-4-ca r b oxy-
bu tylben zoate)]r otaxan e} Tetr akis(h exaflu or oph osph ate)
-
Dim er (30b‚8P F6)). 29b‚4PF6- (17 mg, 6.3 µmol), 28b‚4PF6
-
(28a ‚4P F 6)). To a solution of 1a ‚4PF6 (10 mg, 3.9 µmol) in
(18 mg, 6.3 µmol), DMAP (1.6 mg, 13 µmol), and TosH (2.2
mg, 11 µmol) were dissolved in MeCN (0.2 mL), and DCC (4
mg, 19 µmol) was added. After the reaction was stirred for 1
day at room temperature, DHU was removed by centrifugation
and the product precipitated with CH2Cl2/Et2O. Column chro-
matography [SiO2, MeOH:2 M NH4Cl:MeNO2 (7:2:1) f MeOH:
H2O (7:2) f MeCN + 0.5% NH4PF6] yielded the product as a
CHCl3 (0.4 mL) were added acetic acid (13 µL, 230 µmol) and
NMM (13 µL, 115 µmol). A solution of Pd(PPh3)4 (9 mg, 7.7
µmol) in CHCl3 (0.1 mL) was added, and the reaction mixture
was stirred for 3 h at room temperature. After addition of
CHCl3 (3 mL), the rotaxane was precipitated with Et2O (1 mL).
The solid was extracted with CH2Cl2/H2O and the solvent
evaporated in vacuo, yielding the product as a red solid (7.8
mg, 80%). 1H NMR (CD3CN): δ 1.20 (s, 9H), 2.38 (quintet, 2H),
2.77 (t, 2H), 3.60-4.15 (m, 48H), 4.71 (t, 2H), 5.43 (s, 1H), 5.54
(s, 1H), 6.27 (s, 4H), 6.48 (s, 2H), 6.52 (s, 2H), 6.88 (d, 2H),
7.23 (d, 2H), 7.34-7.61 (m, 21H), 7.85 (d, 4H), 8.16 (s, 4H),
8.30-8.40 (m, 10H), 8.71 (s, 1H), 9.43-9.49 (m, 6H), 9.59 (d,
2H).
1
red solid (27 mg, 78%). H NMR (acetone-d6): δ 1.23 (s, 9H),
2.31-2.46 (m, 4H), 2.75 (t, 4H), 3.75-4.22 (m, 96H), 4.67-
4.79 (m, 6H), 5.35 (d, 1H), 5.47 (d, 1H), 6.12 (m, 1H), 6.19 (s,
8H), 6.26 (s, 2H), 6.32 (s, 2H), 6.53 (s, 4H), 6.81-6.97 (m, 12H),
7.01 (d, 4H), 7.10 (d, 4H), 7.18-7.23 (m, 12H), 7.31-7.45 (m,
42H), 7.52-7.63 (m, 6H), 7.86 (d, 4H), 8.17 (s, 8H), 8.30-8.42
(m, 20H), 8.74 (s, 2H), 9.44-9.50 (m, 12H), 9.56-9.60 (m, 4H).
MALDI-TOF: m/z 4923 (M - 4PF6)+, 4778 (M - 5 PF6)+, 4633
(M - 6PF6)+, 4488 (M - 7 PF6)+, 4343 (M - 8PF6)+.
{[1-{p -[2-(2-(2-(2-(D i p h e n y lm e t h o x y )e t h o x y )e t h -
oxy)e t h oxy)e t h oxy]p h e n oxy}-13-{p -[2-(2-(2-(2-[4-h y-
d r oxyp h en yl]p h en ylm et h oxy)et h oxy)et h oxy)et h oxy)-
e t h o x y ]p h e n o x y }-3,6,9-t r io x a u n d e c a n e ][c y c lo (2,5-
(p a r a q u a t -p -p h e n yle n e p a r a q u a t )(a llyl-4-b u t a n oa t e )-
b en zoa t e)]r ot a xa n e} Tet r a k is(h exa flu or op h osp h a t e)
(29a ‚4P F 6)). o-Nitrophenol (0.6 mg, 4.3 µmol) and Bu4NF (9.5
-
Dim er )COOH (31b‚8P F 6)): To a solution of 30b‚8PF6
(27 mg, 4.9 µmol) in CHCl3 (0.1 mL) were added acetone (0.1
mL), acetic acid (17 µL, 0.30 mmol), and NMM (16 µL, 0.15
mmol). A solution of Pd(PPh3)4 (11 mg, 10 µmol) in CHCl3 (0.1
mL) was added, and the reaction mixture was stirred for 7 h
at room temperature. After addition of CH2Cl2 (2 mL), the
rotaxane was precipitated with Et2O (1 mL). PPh3 was
removed by precipitation with acetone. The solution was
extracted twice with CH2Cl2/NH4PF6 and twice with CH2Cl2/
H2O. Column chromatography [SiO2, MeCN:MeOH:NH4PF6 (9:
1:0% f 9:1:1%)] yielded the product as a red solid (11 mg,
40%). 1H NMR (acetone-d6): δ 1.23 (s, 9H), 2.31-2.46 (m, 4H),
2.75 (t, 4H), 3.75-4.22 (m, 96H), 4.67-4.79 (m, 4H), 6.19 (s,
8H), 6.26 (s, 2H), 6.32 (s, 2H), 6.53 (s, 4H), 6.81-6.97 (m, 12H),
7.01 (d, 4H), 7.10 (d, 4H), 7.18-7.23 (m, 12H), 7.31-7.45 (m,
42H), 7.52-7.63 (m, 6H), 7.86 (d, 4H), 8.17 (s, 8H), 8.30-8.42
(m, 20H), 8.74 (s, 2H), 9.44-9.50 (m, 12H), 9.56-9.60 (m, 4H).
MALDI-TOF (dihydroxybenzoic acid matrix): m/z 4738 (M
- 5 PF6)+, 4593 (M - 6PF6)+, 4448 (M - 7 PF6)+;
-
µL, 9.5 µmol) were added to a solution of 1a ‚4PF6 (10 mg,
3.9 µmol) in MeCN (0.2 mL). After 30 min, the rotaxane was
precipitated with water and centrifuged. The solid was dis-
solved in CHCl3 (2 mL) and precipitated with Et2O (1 mL)
twice, yielding the product as a red solid (6.4 mg, 70%). 1H
NMR (CD3CN): δ 2.38 (quintet, 2H), 2.77 (t, 2H), 3.60-4.15
(m, 48H), 4.70-4.76 (m, 4H), 5.22 (d, 1H), 5.28-5.43 (m, 3H),
6.10 (m, 1H), 6.27 (s, 4H), 6.48 (s, 2H), 6.52 (s, 2H), 6.90 (d,
2H), 7.25 (d, 2H), 7.34-7.49 (m, 15H), 8.16 (s, 4H), 8.30-8.40
(m, 9H), 8.61 (s, 1H), 8.71 (s, 1H), 9.43-9.49 (m, 6H), 9.59 (d,
2H).
{[1-{p -[2-(2-(2-(2-(4-Tr it ylp h e n oxy)e t h oxy)e t h oxy)-
e t h o x y )e t h o x y ]p h e n o x y }-13-{p -[2-(2-(2-(2-(4-[4-((d i-
p h e n yl-t er t -b u t yl)siloxy)]t r it ylp h e n oxy)e t h oxy)e t h -
oxy)eth oxy)eth oxy]p h en oxy}-3,6,9-tr ioxa u n d eca n e][cy-
clo(2,5-(p a r a q u a t -p -p h en ylen ep a r a q u a t )-4-ca r b oxyb u -
tylben zoa te)]r ota xa n e} Tetr a k is(h exa flu or op h osp h a te)
Dim er )OH (32b‚8P F 6)): o-Nitrophenol (0.9 mg, 7 µmol)
and Bu4NF (6 µL, 6 µmol) were added to a solution of
30b‚8PF6- (27 mg, 4.8 µmol) in MeCN (0.2 mL). After 30 min,
CH2Cl2 was added and extracted twice with H2O/NH4PF6 and
twice with water. The rotaxane was precipitated from the
organic phase with Et2O, yielding the product as a red solid
(22 mg, 85%). 1H NMR (acetone-d6): δ 2.31-2.46 (m, 4H), 2.75
(t, 4H), 3.75-4.22 (m, 96H), 4.67-4.79 (m, 6H), 5.35 (d, 1H),
5.47 (d, 1H), 6.12 (m, 1H), 6.19 (s, 8H), 6.26 (s, 2H), 6.32 (s,
2H), 6.53 (s, 4H), 6.81-6.97 (m, 12H), 7.01 (d, 4H), 7.10 (d,
4H), 7.18-7.23 (m, 12H), 7.31-7.45 (m, 42H), 8.17 (s, 8H),
8.30-8.42 (m, 20H), 8.74 (s, 2H), 9.44-9.50 (m, 12H), 9.56-
9.60 (m, 4H). MALDI-TOF (dihydroxybenzoic acid matrix):
m/z 4540 (M - 5 PF6)+, 4395 (M - 6PF6)+, 4250 (M - 7 PF6)+.
-
(28b‚4P F 6)): To a solution of 1b‚4PF6 (64 mg, 22 µmol) in
CHCl3 (0.5 mL), were added acetone (0.2 mL), acetic acid (76
µL, 1.33 mmol), and NMM (73 µL, 0.66 mmol). A solution of
Pd(PPh3)4 (51 mg, 44 µmol) in CHCl3 (0.5 mL) was added, and
the reaction mixture was stirred for 3 h at room temperature.
After addition of CHCl3 (3 mL), the rotaxane was precipitated
with Et2O (1 mL). PPh3 was removed by precipitation with
acetone. Evaporation of the solvent in vacuo yielded the
1
product as a red solid (50 mg, 80%). H NMR (acetone-d6): δ
1.24 (s, 9H), 2.33 (quintet, 2H), 2.71 (t, 2H), 3.78-4.21 (m,
48H), 4.71 (t, 2H), 6.20 (s, 4H), 6.31 (s, 2H), 6.54 (s, 2H), 6.82-
6.93 (m, 6H), 7.02 (d, 2H), 7.11 (d, 2H), 7.18-7.23 (m, 6H),
7.30-7.44 (m, 21H), 7.52-7.61 (m, 6H), 7.86 (d, 4H), 8.17 (s,
4H), 8.31-8.41 (m, 10H), 8.73 (s, 1H), 9.46-9.53 (m, 6H), 9.58
(d, 2H). MALDI-TOF (dihydroxybenzoic acid matrix): m/z
2563 (M - 2PF6)+, 2418 (M - 3PF6)+, 2273 (M - 4PF6)+.
{[1-{p -[2-(2-(2-(2-(D i p h e n y lm e t h o x y )e t h o x y )e t h -
oxy)et h oxy)et h oxy]p h en oxy}-13-{p -[2-(2-(2-(2-(4-[4-h y-
d r oxyt r it ylp h e n oxy)e t h oxy)e t h oxy)e t h oxy)e t h oxy]-
p h en oxy}-3,6,9-t r ioxa u n d eca n e][cyclo(2,5-(p a r a q u a t -p-
p h en ylen ep a r a qu a t)(a llyl-4-bu ta n oa te)ben zoa te)]r ota x-
an e} Tetr akis(h exaflu or oph osph ate) (29b‚4P F6)). o-Nitro-
phenol (4.2 mg, 0.03 mmol) and Bu4NF (27 µL, 0.03
-
Tetr a m er (33b‚16P F 6)): Dimer-COOH 31b‚8PF6 (6.9
-
mg, 1.3 µmol) and Dimer-OH 32b‚8PF6 (5.6 mg, 1.1 µmol)
were dissolved in dry MeCN (0.15 mL). DMAP (0.26 mg, 2.1
µmol) in MeCN (10 µL), TosH (0.4 mg, 2.0 µmol) in MeCN (10
µL), and DCC (0.9 mg, 4.2 µmol) in MeCN (10 µL) were added.
After 4 days at room temperature, DCC (2 mg) was added.
After 7 days the reaction mixture was extracted with CH2Cl2/
NH4PF6 and twice with CH2Cl2/H2O, and the product subse-
quently precipitated from CH2Cl2/Et2O. Column chromatog-
raphy [SiO2, MeCN:MeOH:NH4PF6 (9:1:0% f 9:1:1.5%)] yielded
the pure tetramer as a red solid (4.0 mg, 35%). 1H NMR
(acetone-d6): δ 1.23 (s, 9H), 2.31-2.46 (m, 8H), 2.75 (t, 8H),
3.75-4.22 (m, 192H), 4.67-4.79 (m, 10H), 5.35 (d, 1H), 5.47
-
mmol) were added to a solution of 1b‚4PF6 (61 mg, 0.02121